Recent Posts by pdx_admin

ResearchDx and Menarini Silicon Biosystems Launch DEPArray HER2 for Breast and GEA Cancers

Novel tissue-based assay digitally isolates pure tumor cell populations for robust assessment of HER2 gene status with single-cell precision Irvine, CA-October 2, 2017-ResearchDx, the leading biopharma companion diagnostics provider and Menarini Silicon Biosystems, worldwide manufacturer of image-based cell sorting products and services, jointly announce the launch of DEPArray HER2. The fluorescence in situ hybridization (FISH)-based…
Read more

Smooth Sailing Across a Changing Landscape: Researchdx/ Pacificdx Represents At The AGT 42nd Annual Meeting, St. Louis, MO June 15-17, 2017

The 42nd Association of Genetic Technologists (AGT) Annual Meeting highlighted the underlying theme of change. Change of professional landscape, AGT Board Management and culture. This theme was established starting from the Thursday workshops focused on Management, Molecular genetics techniques and the economics of novel Cytogenetic and Molecular workflows and propagated throughout the remaining conference agenda.…
Read more

Surveying Genomic Landscapes in the Clinical Laboratory: DNA Views of Tumor Terrain

A web search for the term ‘genomic landscapes’ brings up a surprising number of publications from esteemed journals such as Cell, Science, and Nature Genetics. At first glance it would seem that the words ‘genomic’ and ‘landscape’ do not belong together. However, review of the many ‘genomic landscape’ publications from the past decade reveals a…
Read more

Dr. Phil Cotter to Present at AGT’s 42nd Annual Meeting

St. Louis, MO  – Phil Cotter, PhD, FACMG, FFSc (RCPA),  Laboratory Director and Co-Founder of PacificDx, has been asked to present at the June AGT’s 42nd Annual Meeting speaking on The Pathway to FDA Approval for NGS Companion Diagnostics. The presentation is described as follows – “The FDA has prescribed a pathway for the co-approval of…
Read more

Recent Comments by pdx_admin

No comments by pdx_admin yet.